Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines (Q39528980)

12 September 2017

Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines (English)

1 reference

12 September 2017

Hung-Ju Wei

1

1 reference

12 September 2017

Weihau Chang

2

1 reference

12 September 2017

Shih-Chang Lin

3

1 reference

12 September 2017

Wen-Chun Liu

4

1 reference

12 September 2017

Ding-Kao Chang

5

1 reference

12 September 2017

Pele Chong

6

1 reference

12 September 2017

Suh-Chin Wu

7

1 reference

12 September 2017

language of work or name

English

0 references

publication date

7 June 2011

1 reference

12 September 2017

1 reference

12 September 2017

29

1 reference

12 September 2017

41

1 reference

12 September 2017

7163-7172

1 reference

Influenza: lessons from past pandemics, warnings from current incidents.

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Influenza virus matrix protein is the major driving force in virus budding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Influenza virus-like particle vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

The lack of an inherent membrane targeting signal is responsible for the failure of the matrix (M1) protein of influenza A virus to bud into virus-like particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Baculovirus as versatile vectors for protein expression in insect and mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Induction of long-term protective immune responses by influenza H5N1 virus-like particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Engineering N-glycosylation pathways in the baculovirus-insect cell system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Evidence for a sialic acid salvaging pathway in lepidopteran insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Visualizing infection of individual influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Assembly of endocytic machinery around individual influenza viruses during viral entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Characterization of a neuraminidase-deficient influenza a virus as a potential gene delivery vector and a live vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.05.077

10.1016/J.VACCINE.2011.05.077

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference